Dr. Preeti Yonker, MD

NPI: 1841409000
Total Payments
$24,606
2024 Payments
$3,690
Companies
59
Transactions
1,499
Medicare Patients
2,477
Medicare Billing
$528,387

Payment Breakdown by Category

Food & Beverage$23,949 (97.3%)
Education$458.28 (1.9%)
Other$199.22 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $23,949 1,477 97.3%
Education $458.28 10 1.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $199.22 12 0.8%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $3,656 178 $0 (2024)
Biogen, Inc. $2,043 119 $0 (2024)
UCB, Inc. $1,357 70 $0 (2024)
Genentech USA, Inc. $1,323 83 $0 (2024)
ABBVIE INC. $1,166 82 $0 (2024)
Lilly USA, LLC $1,051 67 $0 (2024)
Novartis Pharmaceuticals Corporation $815.77 65 $0 (2023)
EMD Serono, Inc. $807.82 35 $0 (2024)
ACADIA Pharmaceuticals Inc $716.40 53 $0 (2024)
Eisai Inc. $716.02 52 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,690 159 Teva Pharmaceuticals USA, Inc. ($493.48)
2023 $3,365 171 Teva Pharmaceuticals USA, Inc. ($527.43)
2022 $3,364 198 Teva Pharmaceuticals USA, Inc. ($733.03)
2021 $3,497 219 Teva Pharmaceuticals USA, Inc. ($485.85)
2020 $2,185 141 Teva Pharmaceuticals USA, Inc. ($365.88)
2019 $3,683 246 Biogen, Inc. ($705.47)
2018 $2,716 216 EMD Serono, Inc. ($172.54)
2017 $2,106 149 Teva Pharmaceuticals USA, Inc. ($392.75)

All Payment Transactions

1,499 individual payment records from CMS Open Payments — Page 1 of 60

Date Company Product Nature Form Amount Type
12/31/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $26.47 General
Category: Central Nervous System
12/20/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $22.53 General
Category: Neuroscience
12/19/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $1.94 General
Category: Neuroscience
12/18/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $18.54 General
Category: EPILEPSY
12/18/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $10.04 General
Category: Inflammation/Rare Disease
12/17/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $21.60 General
Category: NEUROLOGY
12/16/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $21.04 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/12/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $30.23 General
Category: Immunology
12/11/2024 ABBVIE INC. VYALEV (Drug) Food and Beverage In-kind items and services $22.11 General
Category: NEUROSCIENCE
12/10/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $19.71 General
Category: BOTOX THERAPEUTIC
12/09/2024 Biogen, Inc. AVONEX (Biological), TYSABRI, VUMERITY Food and Beverage In-kind items and services $23.21 General
Category: Neurology
12/05/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $42.08 General
Category: NEUROLOGY
12/05/2024 Amneal Pharmaceuticals LLC CREXONT (Drug) Food and Beverage In-kind items and services $23.13 General
Category: NEUROLOGY
12/04/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $31.77 General
Category: Central Nervous System
12/02/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $18.00 General
11/20/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $24.36 General
Category: Neuroscience
11/19/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $19.71 General
Category: EPILEPSY
11/18/2024 Amneal Pharmaceuticals LLC CREXONT (Drug) Food and Beverage In-kind items and services $17.68 General
Category: NEUROLOGY
11/13/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $31.22 General
Category: NEUROLOGY
11/12/2024 Biogen, Inc. AVONEX (Biological), TYSABRI, VUMERITY Food and Beverage In-kind items and services $14.50 General
Category: Neurology
11/12/2024 Biogen, Inc. AVONEX (Biological), TYSABRI, VUMERITY Food and Beverage In-kind items and services $8.58 General
Category: Neurology
11/12/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $3.37 General
Category: Central Nervous System
11/11/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $19.70 General
Category: Neurology
11/08/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $20.70 General
Category: Neurology
11/06/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $22.49 General
Category: Inflammation/Rare Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 550 15,753 $311,683 $139,808
2022 7 558 12,322 $261,565 $113,135
2021 9 683 15,095 $334,831 $148,557
2020 11 686 14,243 $301,370 $126,886
Total Patients
2,477
Total Services
57,413
Medicare Billing
$528,387
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 19 15,000 $112,500 $73,949 65.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 233 344 $94,944 $32,216 33.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 198 250 $46,750 $15,476 33.1%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2023 19 76 $28,196 $9,535 33.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 49 49 $20,776 $6,282 30.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 17 17 $6,001 $1,690 28.2%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2023 15 17 $2,516 $660.30 26.2%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 18 11,600 $87,000 $56,528 65.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 205 268 $73,968 $22,622 30.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 264 343 $64,141 $22,098 34.5%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2022 18 57 $20,831 $7,122 34.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 18 18 $7,632 $2,472 32.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 13 13 $4,589 $1,221 26.6%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2022 22 23 $3,404 $1,072 31.5%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2021 21 14,200 $106,500 $68,078 63.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 251 373 $102,948 $36,077 35.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 223 267 $49,929 $17,562 35.2%
64615 Injection of chemical for destruction of facial and neck nerve muscles on both sides of face Office 2021 21 72 $26,712 $9,408 35.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 40 43 $12,212 $5,965 48.8%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 35 35 $14,840 $4,659 31.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 30 30 $10,590 $3,227 30.5%
95819 Measurement and recording of brain wave (eeg) activity, awake and asleep Facility 2021 44 57 $8,436 $2,727 32.3%
95812 Measurement of brain wave (eeg) activity, 41-60 minutes Facility 2021 18 18 $2,664 $855.72 32.1%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2020 20 13,401 $100,508 $64,197 63.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 242 330 $91,080 $26,372 29.0%

About Dr. Preeti Yonker, MD

Dr. Preeti Yonker, MD is a Neurology healthcare provider based in Berlin, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841409000.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Preeti Yonker, MD has received a total of $24,606 in payments from pharmaceutical and medical device companies, with $3,690 received in 2024. These payments were reported across 1,499 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($23,949).

As a Medicare-enrolled provider, Yonker has provided services to 2,477 Medicare beneficiaries, totaling 57,413 services with total Medicare billing of $528,387. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Berlin, MD
  • Active Since 05/22/2007
  • Last Updated 09/27/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1841409000

Products in Payments

  • TYSABRI (Biological) $1,397
  • AUSTEDO (Drug) $1,037
  • AJOVY (Biological) $1,019
  • EMGALITY (Drug) $855.85
  • OCREVUS (Biological) $818.12
  • Briviact (Drug) $768.65
  • ACTHAR (Biological) $730.78
  • RYTARY (Drug) $724.68
  • Austedo XR (Drug) $715.29
  • APTIOM (Drug) $649.33
  • NUPLAZID (Drug) $602.77
  • Fycompa (Drug) $584.56
  • BOTOX (Biological) $555.17
  • NURTEC ODT (Drug) $544.64
  • INGREZZA (Drug) $524.70
  • Aimovig (Biological) $502.85
  • UBRELVY (Drug) $436.16
  • Epidiolex (Drug) $433.32
  • Ocrevus (Biological) $427.82
  • VYEPTI (Biological) $414.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Berlin